Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada Sets Jan 2019 Deadline For Mandatory Adoption Of MDSAP Within Medtech Framework

This article was originally published in SRA

Executive Summary

As of January 2017, medical device manufacturers selling their products in Canada will get two years to comply with the requirements of the Medical Device Single Audit Program. Specifically, after January 2019 MDSAP will become the sole mechanism to demonstrate compliance with Canadian quality management system requirements1.

You may also be interested in...



Canada's Switch From CMDCAS To MDSAP Went Off Without A Hitch – Despite 403 Firms Leaving The Market

It's been one full month since the Medical Device Single Audit Program officially replaced the traditional Canadian Medical Devices Conformity Assessment System (CMDCAS) audits, and Health Canada is claiming success. Although 403 device-makers withdrew from the Canadian market because of the switch to MDSAP, it's nothing to be concerned about, a Health Canada spokesperson says.

India Proposes Tiered Approach To Oversee Genome Editing

India has proposed three categories for grouping genetically edited organisms based on the complexity of modifications.

UK's MHRA Looks Beyond Brexit Transition Period

Now that the UK has left the EU, the UK’s medicines regulator says it will use the rest of this year to work out how best to ensure continuity of drug regulation after the Brexit transition period ends on 31 December.

UsernamePublicRestriction

Register

MT040683

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel